[Italian Acute Stroke Study: hemodilution + drug. Presentation of the protocol]
- PMID: 3043267
[Italian Acute Stroke Study: hemodilution + drug. Presentation of the protocol]
Similar articles
-
GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study--Hemodilution + Drug.Stroke. 1989 Sep;20(9):1143-9. doi: 10.1161/01.str.20.9.1143. Stroke. 1989. PMID: 2672425 Clinical Trial.
-
Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.J Neurosci Res. 1984;12(2-3):493-8. doi: 10.1002/jnr.490120232. J Neurosci Res. 1984. PMID: 6389896 Clinical Trial. No abstract available.
-
Monosialoganglioside GM1 in cerebral ischemia.Cerebrovasc Brain Metab Rev. 1991 Summer;3(2):134-57. Cerebrovasc Brain Metab Rev. 1991. PMID: 1854596 Review.
-
[Trials of monosialoganglioside (Sygen) treatment in ischemic stroke].Neurol Neurochir Pol. 1993 Jan-Feb;27(1):31-8. Neurol Neurochir Pol. 1993. PMID: 8502357 Clinical Trial. Polish.
-
Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.Cell Transplant. 2019 Jun;28(6):657-661. doi: 10.1177/0963689718822782. Epub 2019 Jan 22. Cell Transplant. 2019. PMID: 30666888 Free PMC article. Review.
Cited by
-
Gangliosides for acute ischaemic stroke.Cochrane Database Syst Rev. 2000;2001(2):CD000094. doi: 10.1002/14651858.CD000094. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD000094. doi: 10.1002/14651858.CD000094. PMID: 10796297 Free PMC article. Updated.